Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
112.50
-0.52 (-0.46%)
Dec 5, 2025, 4:00 PM EST - Market closed
Encompass Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Encompass Health stock have an average target of 141.88, with a low estimate of 125 and a high estimate of 160. The average target predicts an increase of 26.12% from the current stock price of 112.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 30, 2025.
Analyst Ratings
The average analyst rating for Encompass Health stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 6 | 6 | 4 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $141 → $150 | Buy | Maintains | $141 → $150 | +33.33% | Oct 30, 2025 |
| UBS | UBS | Strong Buy Maintains $140 → $150 | Strong Buy | Maintains | $140 → $150 | +33.33% | Oct 2, 2025 |
| Keybanc | Keybanc | Buy Maintains $135 → $140 | Buy | Maintains | $135 → $140 | +24.44% | Sep 16, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $145 → $160 | Strong Buy | Maintains | $145 → $160 | +42.22% | Sep 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $135 → $140 | Strong Buy | Maintains | $135 → $140 | +24.44% | Aug 14, 2025 |
Financial Forecast
Revenue This Year
5.99B
from 5.37B
Increased by 11.54%
Revenue Next Year
6.52B
from 5.99B
Increased by 8.78%
EPS This Year
5.35
from 4.46
Increased by 20.04%
EPS Next Year
5.87
from 5.35
Increased by 9.64%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.3B | 6.8B | ||
| Avg | 6.0B | 6.5B | ||
| Low | 5.8B | 6.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 16.5% | 13.9% | ||
| Avg | 11.5% | 8.8% | ||
| Low | 8.1% | 4.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 5.62 | 6.52 | ||
| Avg | 5.35 | 5.87 | ||
| Low | 5.15 | 5.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 26.0% | 21.8% | ||
| Avg | 20.0% | 9.6% | ||
| Low | 15.4% | -0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.